Assessment and Treatment of IBS with Cramping and No Nausea

Initial Assessment and Diagnosis

The American Gastroenterological Association recommends making a positive diagnosis using symptom-based criteria without extensive testing if the patient is under 45 years old and lacks alarm features, such as unintentional weight loss, rectal bleeding, or recent change in bowel function 2, 3

The American College of Gastroenterology suggests prescribing regular physical exercise to all IBS patients, as this provides significant benefits for global symptom management 1, 2, 3
The American Gastroenterological Association recommends starting soluble fiber supplementation (ispaghula/psyllium) at 3-4 g/day, gradually increasing to 25 g/day to avoid bloating, while avoiding insoluble fiber (wheat bran) which worsens symptoms 1, 2, 3
The National Institute of Diabetes and Digestive and Kidney Diseases advises identifying and reducing excessive intake of lactose, fructose, sorbitol, caffeine, or alcohol if diarrhea is present 5, 2, 3

The American College of Gastroenterology recommends prescribing dicyclomine 40 mg four times daily (160 mg total daily dose) for cramping, particularly when symptoms are meal-exacerbated 4, 2, 3
The American Gastroenterological Association suggests considering peppermint oil as an antispasmodic with fewer side effects if dicyclomine is not tolerated 5, 1, 2, 3

The American College of Gastroenterology advises initiating amitriptyline 10 mg once daily at bedtime for refractory cramping and global symptoms, titrating slowly (by 10 mg/week) to 30-50 mg daily 1, 2, 3
The National Institute of Diabetes and Digestive and Kidney Diseases recommends continuing amitriptyline for at least 6 months if the patient reports symptomatic improvement 1, 2, 3

The American Gastroenterological Association warns against prescribing anticholinergic antispasmodics like dicyclomine for constipation-predominant IBS without adequate laxative therapy, as they can worsen constipation 1
The American College of Gastroenterology advises against opioids for chronic abdominal pain management due to risks of dependence, complications, and potential worsening of constipation 2, 3